Connect with us

Published

on

The marketing pitches are bold and arriving fast: Invest opioid settlement dollars in a lasso-like device to help police detain people without Tasers or pepper spray. Pour money into psychedelics, electrical stimulation devices, and other experimental treatments for addiction. Fund research into new, supposedly abuse-deterrent opioids and splurge on expensive, brand-name naloxone.

This story also ran on Fortune. It can be republished for free. More from This InvestigationPayback: Tracking the Opioid Settlement Cash

Opioid manufacturers and distributors are paying more than $54 billion in restitution to settle lawsuits about their role in the overdose epidemic, with little oversight on how the money is spent. Were tracking how state and local governments use or misuse the cash.Read More

These pitches land daily in the inboxes of state and local officials in charge of distributing more than $50 billion from settlements in opioid lawsuits.

The money is coming from an array of companies that made, sold, or distributed prescription painkillers, including Johnson & Johnson, AmerisourceBergen, and Walgreens. Thousands of state and local governments sued the companies for aggressively promoting and distributing opioid medications, fueling an epidemic that progressed to heroin and fentanyl and has killed more than half a million Americans. The settlement money, arriving over nearly two decades, is meant to remediate the effects of that corporate behavior.

But as the dollars land in government coffers more than $4.3 billion as of early November a swarm of private, public, nonprofit, and for-profit entities are eyeing the gold rush. Some people fear that corporations, in particular with their flashy products, robust marketing budgets, and hunger for profits will now gobble up the windfall meant to rectify it.

They see a cash cow, said JK Costello, director of behavioral health consulting for the Steadman Group, a firm that is being paid to help local governments administer the settlements in Colorado, Kansas, Oregon, and Virginia. Everyone is interested.

Costello receives multiple emails a week from businesses and nonprofits seeking guidance on how to apply for the funds. To keep up with the influx, he has developed a standard response: Thanks, but we cant respond to individual requests, so heres a link to your localitys website, public meeting schedule, or application portal. Email Sign-Up

Subscribe to KFF Health News' free Morning Briefing. Your Email Address Sign Up

KFF Health News obtained email records in eight states that show health departments, sheriffs offices, and councils overseeing settlement funds are receiving a similar deluge of messages. In the emails, marketing specialists offer phone calls, informational presentations, and meetings with their companies.

Alabama Attorney General Steve Marshall recently sent a letter reminding local officials to vet organizations that reach out. I am sure that many of you have already been approached by a variety of vendors seeking funding for opioid initiatives, he wrote. Please proceed with caution.

Of course, not all marketing efforts should prompt concern. Emails and calls are one way people in power learn about innovative products and services. The countrys addiction crisis is too large for the public sector to tame alone, and many stakeholders agree that partnering with industry is crucial. After all, pharmaceutical companies manufacture medications to treat opioid addiction. Corporations run treatment facilities and telehealth services.

Its unrealistic and even harmful to say we dont want any money going to any private companies, said Kristen Pendergrass, vice president of state policy at Shatterproof, a national nonprofit focused on addiction.

The key, agree public health and policy experts, is to critically evaluate products or services to see if they are necessary, evidence-based, and sustainable instead of flocking to companies with the best marketing.

Otherwise, you end up with lots of shiny objects, Costello said. Carolyn Williams lost her 47-year-old son, Haison Akiem Williams, to an overdose in February. She wants settlement funds to support services she thinks could have kept him alive: mental health treatment, case management, and housing. In June, she spoke at a protest outside a Drug Enforcement Administration building in Arlington, Virginia, where people called for an end to a criminal justice approach to addiction.(Aneri Pattani/KFF Health News)

And, ultimately, failure to do due diligence could leave some jurisdictions holding an empty bag.

Take North Carolina. In 2022, state lawmakers allotted $1.85 million of settlement funds for a pilot project using the first FDA-approved app for opioid use disorder, developed by Pear Therapeutics. There were high hopes the app would help people stay in treatment longer.

But less than a year later, Pear Therapeutics filed for bankruptcy.

The state hadnt paid the company yet, so the money isn’t lost, according to the North Carolina Department of Health and Human Services. But the department and lawmakers have not decided what to do with those dollars next.

$1 Million for Drug Disposal Pouches

Jason Sundby, CEO of Verde Environmental Technologies, said the Deterra pouches his company sells are a low-cost way to prevent expensive addictions.

Customers place their unused medications in a Deterra pouch and add water, deactivating the drugs before tossing them, ensuring they cannot be used even if fished out of the trash. A medium Deterra pouch costs $3.89 and holds 45 pills.

The goal is to get these drugs out of people’s homes before they can be misused, diverted, and people start down the path of needing treatment or naloxone or emergency room visits, Sundby said.

Sundbys company ran an ad about spending settlement dollars on its product in a National Association of Counties newsletter and featured similar information online. The Deterra website prominently features opioid settlement funds as a potential funding stream to purchase drug disposal pouches. Several other companies have taken similar approaches, urging consumers to consider applying opioid settlement funds to their products. (KFF Health News screenshot of https://deterrasystem.com/resources/funding/ on Nov. 21, 2023)

It may be paying off, as Deterra is set to receive $1 million in settlement funds from the health department in Delaware County, Pennsylvania, and $12,000 from the sheriffs office in Henry County, Iowa. The company also has partnerships with St. Croix and Milwaukee counties in Wisconsin, and is working on a deal in Connecticut.

Several other companies with similar products have also used their product sites to urge jurisdictions to consider the settlements as a funding stream and theyre seeing early success.

DisposeRx makes a drug deactivation product its version costs about a dollar each and received $144,000 in South Carolina for mailing 134,000 disposal packets to a program that educated high school football players, coaches, and parents about addiction.

SafeRx makes $3 pill bottles with a locking code to store medications and was awarded $189,000 by South Carolinas opioid settlement council to work with the Greenville County Sheriffs Office and local prevention groups. It also won smaller awards from Weld and Custer counties in Colorado.

None of the companies said they are dependent on opioid settlements to sustain their business long-term. But the funds provide a temporary boost. In a 2022 presentation to prospective investors, SafeRx called the opioid settlements a growth catalyst.

Critics of such investments say the products are not worthwhile. Todays crisis of fatal overdoses is largely driven by illicit fentanyl. Even if studies suggest the companies products make people more likely to safely store and dispose of medications, thats unlikely to stem the record levels of deaths seen in recent years.

The plausible mechanism by which they would even be able to reduce overdoseis a mystery because prescription medications are not driving overdose, said Tricia Christensen, policy director with the nonprofit Community Education Group, which is tracking settlement spending across Appalachia.

Safe storage and disposal can be accomplished with a locking cabinet and toilet, she said. The FDA lists opioids on its flush list for disposal and says there is no evidence that low levels of the medicines that end up in rivers harm human health.

But Milton Cohen, CEO of SafeRxs parent company, Caring Closures International, said keeping prescription medicines secure addresses the root of the epidemic. Fentanyl kills, but often where people start, where water is coming into the boat still, is the medicine cabinet, he said. We can bail all we want, but the right thing to do is to plug the hole first. SafeRx has been awarded $189,000 in opioid settlement funds in South Carolina to work with the Greenville County Sheriffs Office and local prevention groups.(Caring Closures International)

Products to secure and dispose of drugs also provide an opportunity for education and destigmatization, said Melissa Lyon, director of the Delaware County Health Department in Pennsylvania. The county will be mailing Deterra pouches and postcards about preventing addiction to three-quarters of its residents.

The Deterra pouch is to me a direct correlation to the overprescribing that came from pharmaceutical companies aggressive marketing, she added. Since the settlement money is to compensate for that, this is a good use of the funds.

Tools for Law Enforcement That Superheroes Would Envy

Other businesses making pitches for settlement funds have a less clear relationship to opioids.

Wrap Technologies creates tools for law enforcement to reduce lethal uses of force. Its chief product, the BolaWrap, shoots a 7-foot Kevlar tether more than a dozen feet through the air until it wraps around a persons limbs or torso almost like Wonder Womans Lasso of Truth. Brownwood, Texas, has spent about $15,000 of opioid settlement funds to buy nine BolaWrap devices.(Wrap Technologies)

Terry Nichols, director of business development for the company, said the BolaWrap can be used as an alternative to Tasers or pepper spray when officers need to detain someone experiencing a mental health crisis or committing crimes related to their addiction, like burglary.

If you want to be more humane in the way you treat people in substance use disorder and crisis, this is an option, he said.

The company posts body camera footage of officers using BolaWrap on YouTube and says that out of 192 field reports of its use, about 75% of situations were resolved without additional use of force.

When officers de-escalate situations, people are less likely to end up in jail, Nichols said. And diverting people from the criminal justice system is among the suggested investments in opioid settlement agreements.

That argument convinced the city of Brownwood, Texas, where Nichols was police chief until 2019. It has spent about $15,000 of opioid settlement funds to buy nine BolaWrap devices.

Our goal is to avoid using force when a citizen is in need, said James Fuller, assistant police chief in Brownwood. If were going to take someone to get help, the last thing we want to do is poke holes in them with a Taser.

After Brownwoods purchase, Wrap Technologies issued a press release in which CEO Kevin Mullins encouraged more law enforcement agencies to take the opportunity afforded by the opioid settlement funds to empower their officers. The company has also sent a two-page document to police departments explaining how settlement funds can be used to buy BolaWraps.

Language from that document appeared nearly word-for-word in a briefing sheet given to Brownwood City Council before the BolaWrap purchase. The council voted unanimously in favor.

But the process hasnt been as smooth elsewhere. In Hawthorne, California, the police department planned to buy 80 BolaWrap devices using opioid settlement funds. It paid its first installment of about $25,000 in June. However, it was later informed by the state Department of Health Care Services that the BolaWrap is not an allowable use of these dollars.

Bola Wraps will not be purchased with the Settlement Funds in the future, Hawthorne City Clerk Dayna Williams-Hunter wrote in an email.

Carolyn Williams, a member of the advocacy group Vocal-TX, said she doesnt see how the devices will address the overdose crisis in Texas or elsewhere.

Her son Haison Akiem Williams dealt with mental health and addiction issues for years. Without insurance, he couldnt afford rehab. When he sought case management services, there was a three-month wait, she said. Police charged him with misdemeanors but never connected him to care, she said. Share Your Story

Do you have concerns about how your state or locality is using the opioid settlement funds? Are they doing something effective that other places should replicate? Tell us here.Share Your Story

In February, he died of an overdose at age 47. His mother misses how he used to make her laugh by calling her Ms. Carol.

She wants settlement funds to support services she thinks could have kept him alive: mental health treatment, case management, and housing. BolaWrap doesnt make that list.

Its heartbreaking to see what the government is doing with this money, she said. Putting it in places they really don’t need it.

Aneri Pattani: apattani@kff.org, @aneripattani Related Topics Multimedia Public Health States Alabama California Colorado Connecticut Investigation Iowa North Carolina Opioid Settlements Opioids Pennsylvania South Carolina Texas Wisconsin Contact Us Submit a Story Tip

Continue Reading

Entertainment

‘Beloved and inspirational’ author Joanna Trollope dies

Published

on

By

'Beloved and inspirational' author Joanna Trollope dies

Author Joanna Trollope has died aged 82, her family has said.

Trollope was one of the nation’s most widely read authors, having published more than 30 novels during a career that began in the 1970s.

Her novels include “Aga sagas” The Rector’s Wife, Marrying The Mistress and Daughters-in-Law.

In a statement, Trollope’s daughters Antonia and Louise said: “Our beloved and inspirational mother Joanna Trollope has died peacefully at her Oxfordshire home, on December 11, aged 82.”

Trollope with Queen Elizabeth II in 2001. Pic: PA
Image:
Trollope with Queen Elizabeth II in 2001. Pic: PA

Her literary agent James Gill said: “It is with great sadness that we learn of the passing of Joanna Trollope, one of our most cherished, acclaimed and widely enjoyed novelists.

“Joanna will be mourned by her children, grandchildren, family, her countless friends and – of course – her readers.”

Trollope was born in Gloucestershire in 1943. She won a scholarship to study at the University of Oxford in the 1960s.

After graduating, she joined the Foreign Office before training as a teacher and then turning to writing full-time in 1980.

The author was best known for her novels set in rural middle England and centred around domestic life and relationships.

Her early historical romances were written under the pseudonym Caroline Harvey, before she turned to contemporary fiction.

Her work tackled a range of topics from affairs, blended families and adoption, to parenting and marital breakdown.

Trollope with shortlisted novels for the Orange Prize for Fiction. Pic: PA
Image:
Trollope with shortlisted novels for the Orange Prize for Fiction. Pic: PA

Trollope also took part in The Austen Project, which saw six of Jane Austen’s novels retold by contemporary writers.

She wrote the first book in the series, Sense & Sensibility, published in 2013.

Read more from Sky News:
Man found guilty of murdering wife in rare retrial

UK ‘rapidly developing’ plans to prepare for war

In 1996, Trollope was awarded the Order of the British Empire (OBE) for her services to literature and later made a Commander of the Order of the British Empire (CBE) in 2019.

She won the Romantic Novel of the Year in 1980 for the book Parson Harding’s Daughter and in 2010 was given a lifetime achievement award from the Romantic Novelists’ Association (RNA) for her services to romance.

She went on to chair a number of award ceremonies, including the Costa Book Awards, formerly the Whitbread Prize, as well as the BBC National Short Story Award and the Orange Prize for Fiction.

Continue Reading

Entertainment

Actor and comedian Stanley Baxter dies

Published

on

By

Actor and comedian Stanley Baxter dies

Glaswegian comic actor and impressionist Stanley Baxter has died at the age of 99.

Baxter was bold enough to mimic the Pope and even the Queen and sent up his native city with comic routines based on Glaswegian patois.

The Scot received several awards during his career, including a lifetime achievement award at the British Comedy Awards and two TV tribute programmes.

His friend and biographer Brian Beacom said the TV star died on Thursday in a north London care home for entertainment figures.

He had lived in the home, Denville Hall, since late 2023 and was a few months away from celebrating his 100th birthday.

Pic: PA
Image:
Pic: PA

Baxter’s TV shows, in which he often appeared grotesquely in drag, attracted huge audiences and marked him out as one of the funniest, as well as sometimes one of the most controversial, comics of his generation.

Baxter was also popular on the Scottish pantomime circuit, until his retirement in 1991.

Although he did emerge occasionally and briefly from retirement, he largely disappeared from show business and from the public eye.

Baxter was married for 46 years. His wife, Moira died in 1997.

In 2020, he released a co-written biography, The Real Stanley Baxter, which revealed he was gay and had told his wife before they married.

Baxter was born on 24 May, 1926 and started his career as a child actor in the Scottish edition of BBC’s Children’s Hour.

During his National Service, he developed his skills in the Combined Services Entertainment Unit.

Read more from Sky News:
Man found guilty of murdering wife in rare retrial
King to share personal cancer update in video message

He then returned to Glasgow, and later to London, where he launched a glittering career in television.

He made his debut in the BBC’s Shop Window in 1952, followed by several guest appearances in variety shows.

But it was on the satirical BBC show On The Bright Side (1959) that he was handed his major TV break.

The Stanley Baxter Show (1963-1971) cemented his reputation and propelled him to television stardom.

Scots comedian Stanley Baxter and Julie Dean, a Brian Rogers dancer, rehearsing for Stanley Baxter on Television in 1979. Pic: PA
Image:
Scots comedian Stanley Baxter and Julie Dean, a Brian Rogers dancer, rehearsing for Stanley Baxter on Television in 1979. Pic: PA

Baxter also starred in various TV spectaculars, including Stanley Baxter’s Christmas Box.

Among his most successful routines was Parliamo Glasgow, which was conceived as being written by a fictitious scholar visiting the city.

The sketch took the Glasgow patois and developed it to comic effect, such as “sanoffy cold day” for “It’s an awfully cold day”.

Stanley Baxter in 1969. Pic: Shutterstock
Image:
Stanley Baxter in 1969. Pic: Shutterstock

After his retirement, he appeared in 2004 in a series of three half-hour sitcoms for BBC Radio 4, entitled Stanley Baxter and Friends.

He also lent his voice to the animated children’s film Arabian Knight and the television series Meeow.

Baxter appeared in a number of films, including Very Important Person (1961), in which he played a fiercely nationalistic Scot.

Other film appearances included Geordie (1955), The Fast Lady (1962) and And Father Came Too! (1963).

Baxter also gained an Outstanding Contribution to Film and Television Award from Bafta Scotland in a digital ceremony in 2020.

Continue Reading

Environment

Tesla US sales drop to under 40,000 units following tax credit expiration, lowest in years

Published

on

By

Tesla US sales drop to under 40,000 units following tax credit expiration, lowest in years

Tesla’s US sales have taken a significant hit in November, dropping to just 39,800 units according to new data. This comes as the market adjusts to the expiration of the federal tax credit, despite Tesla’s attempt to mitigate the blow with more discounts.

Since the federal EV tax credit expired at the end of September, the US electric vehicle market has been in a bit of a turmoil. We expected a hangover period after the rush to buy in Q3, but the numbers for November are stark.

According to new estimates from Cox Automotive (via Reuters), Tesla sold approximately 39,800 vehicles in the US in November.

That represents a roughly 23% drop compared to the 51,513 vehicles delivered in November 2024. It is also reportedly Tesla’s lowest monthly sales volume in the US since January 2022.

Advertisement – scroll for more content

It’s important to note that Tesla doesn’t release monthly sales numbers and therefore, those are estimates based on data collected by Cox.

The drop comes despite Tesla’s best efforts to stimulate demand. Following the expiration of the $7,500 federal tax credit, the automaker launched new “Standard” range versions of the Model 3 and Model Y in October, priced roughly $5,000 lower than the previous base models to offset the loss of the incentive.

Those vehicles are expected to start more meaningfully contributing to sales next year.

However, Cox Automotive suggests this strategy could have a minimal impact. Stephanie Valdez Streaty, Cox’s director of industry insights, noted:

“The drop certainly shows there is not enough demand for the Standard variants that were supposed to boost sales after the tax credit expiry. What’s also happening is Standard sales are cannibalizing into sales of Premium versions, especially the Model 3.”

While a 23% drop looks bad on paper, it is worth noting that Tesla is actually weathering the storm better than the rest of the EV market.

Overall US EV sales reportedly plummeted by over 41% in November. Because Tesla’s decline was less severe than its competitors, the company actually saw its market share increase to 56.7%, up from 43.1% a year ago.

Most other automakers relied heavily on the tax credit to move their electric inventory, and without it, they are seeing demand evaporate much faster than Tesla.

Electrek’s Take

It’s sad to see. Elon Musk, Tesla’s CEO, pushed for this to happen, and he always said that he believed Tesla would fare better than other automakers without the tax credit. He was right. The sad part is that it goes completely against Tesla’s mission to accelerate the advent of electric transportation.

Tesla used US incentives as a ladder to reach volume production, and as soon as it did, it pulled the ladder behind it so others couldn’t use it.

What a shame.

And all for what? To be a bigger fish in a smaller pond? Because that’s only going to work in the US. In Europe and China, Tesla’s sales are declining, while other automakers’ EV sales are surging.

FTC: We use income earning auto affiliate links. More.

Continue Reading

Trending